최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecules and cells, v.44 no.6, 2021년, pp.384 - 391
Park, Sung Ho (Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST))
The recent appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people around the world and caused a global pandemic of coronavirus disease 2019 (COVID-19). It has been suggested that uncontrolled, exaggerated inflammation contributes to the adverse out...
Abers M.S. Delmonte O.M. Ricotta E.E. Fintzi J. Fink D.L. de Jesus A.A.A. Zarember K.A. Alehashemi S. Oikonomou V. Desai J.V. 2021 An immune-based biomarker signature is associated with mortality in COVID-19 patients JCI Insight 6 e144455 10.1172/jci.insight.144455 33232303
Arunachalam P.S. Wimmers F. Mok C.K.P. Perera R. Scott M. Hagan T. Sigal N. Feng Y. Bristow L. Tak-Yin Tsang O. 2020 Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans Science 369 1210 1220 10.1126/science.abc6261 32788292
Bastard P. Rosen L.B. Zhang Q. Michailidis E. Hoffmann H.H. Zhang Y. Dorgham K. Philippot Q. Rosain J. Beziat V. 2020 Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Science 370 eabd4585 10.1126/science.abd4585 32972996
Bernardes J.P. Mishra N. Tran F. Bahmer T. Best L. Blase J.I. Bordoni D. Franzenburg J. Geisen U. Josephs-Spaulding J. 2020 Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 Immunity 53 1296 1314.e9 10.1016/j.immuni.2020.11.017 33296687
Blanco-Melo D. Nilsson-Payant B.E. Liu W.C. Uhl S. Hoagland D. Moller R. Jordan T.X. Oishi K. Panis M. Sachs D. 2020 Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Cell 181 1036 1045.e9 10.1016/j.cell.2020.04.026 32416070
Bost P. Giladi A. Liu Y. Bendjelal Y. Xu G. David E. Blecher-Gonen R. Cohen M. Medaglia C. Li H. 2020 Host-viral infection maps reveal signatures of severe COVID-19 patients Cell 181 1475 1488.e12 10.1016/j.cell.2020.05.006 32479746
Brodin P. 2021 Immune determinants of COVID-19 disease presentation and severity Nat. Med. 27 28 33 10.1038/s41591-020-01202-8 33442016
Brunetta E. Folci M. Bottazzi B. De Santis M. Gritti G. Protti A. Mapelli S.N. Bonovas S. Piovani D. Leone R. 2021 Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 Nat. Immunol. 22 19 24 10.1038/s41590-020-00832-x 33208929
Cameron M.J. Ran L. Xu L. Danesh A. Bermejo-Martin J.F. Cameron C.M. Muller M.P. Gold W.L. Richardson S.E. Poutanen S.M. 2007 Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome J. Virol. 81 8692 8706 10.1128/JVI.00527-07 17537853
Carvelli J. Demaria O. Vely F. Batista L. Chouaki Benmansour N. Fares J. Carpentier S. Thibult M.L. Morel A. Remark R. 2020 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis Nature 588 146 150 10.1038/s41586-020-2600-6 32726800
Channappanavar R. Fehr A.R. Zheng J. Wohlford-Lenane C. Abrahante J.E. Mack M. Sompallae R. McCray P.B. Jr. Meyerholz D.K. Jr. Perlman S. Jr. 2019 IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes J. Clin. Invest. 129 3625 3639 10.1172/JCI126363 31355779
Chen J. Ivashkiv L.B. 2010 IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling Proc. Natl. Acad. Sci. U. S. A. 107 19438 19443 20974955
Chua R.L. Lukassen S. Trump S. Hennig B.P. Wendisch D. Pott F. Debnath O. Thurmann L. Kurth F. Volker M.T. 2020 COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis Nat. Biotechnol. 38 970 979 10.1038/s41587-020-0602-4 32591762
Combes A.J. Courau T. Kuhn N.F. Hu K.H. Ray A. Chen W.S. Chew N.W. Cleary S.J. Kushnoor D. Reeder G.C. 2021 Global absence and targeting of protective immune states in severe COVID-19 Nature 591 124 130 10.1038/s41586-021-03234-7 33494096
Consiglio C.R. Cotugno N. Sardh F. Pou C. Amodio D. Rodriguez L. Tan Z. Zicari S. Ruggiero A. Pascucci G.R. 2020 The immunology of multisystem inflammatory syndrome in children with COVID-19 Cell 183 968 981.e7 10.1016/j.cell.2020.09.016 32966765
Del Valle D.M. Kim-Schulze S. Huang H.H. Beckmann N.D. Nirenberg S. Wang B. Lavin Y. Swartz T.H. Madduri D. Stock A. 2020 An inflammatory cytokine signature predicts COVID-19 severity and survival Nat. Med. 26 1636 1643 10.1038/s41591-020-1051-9 32839624
Fajgenbaum D.C. June C.H. 2020 Cytokine storm N. Engl. J. Med. 383 2255 2273 10.1056/NEJMra2026131 33264547
Galani I.E. Rovina N. Lampropoulou V. Triantafyllia V. Manioudaki M. Pavlos E. Koukaki E. Fragkou P.C. Panou V. Rapti V. 2021 Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison Nat. Immunol. 22 32 40 10.1038/s41590-020-00840-x 33277638
Giamarellos-Bourboulis E.J. Netea M.G. Rovina N. Akinosoglou K. Antoniadou A. Antonakos N. Damoraki G. Gkavogianni T. Adami M.E. Katsaounou P. 2020 Complex immune dysregulation in COVID-19 patients with severe respiratory failure Cell Host Microbe 27 992 1000.e3 10.1016/j.chom.2020.04.009 32320677
Grant R.A. Morales-Nebreda L. Markov N.S. Swaminathan S. Querrey M. Guzman E.R. Abbott D.A. Donnelly H.K. Donayre A. Goldberg I.A. 2021 Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia Nature 590 635 641 10.1038/s41586-020-03148-w 33429418
Hadjadj J. Yatim N. Barnabei L. Corneau A. Boussier J. Smith N. Pere H. Charbit B. Bondet V. Chenevier-Gobeaux C. 2020 Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Science 369 718 724 10.1126/science.abc6027 32661059
Ivashkiv L.B. 2018 IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy Nat. Rev. Immunol. 18 545 558 29921905
Ivashkiv L.B. Donlin L.T. 2014 Regulation of type I interferon responses Nat. Rev. Immunol. 14 36 49 10.1038/nri3581 24362405
Kapellos T.S. Bonaguro L. Gemund I. Reusch N. Saglam A. Hinkley E.R. Schultze J.L. 2019 Human monocyte subsets and phenotypes in major chronic inflammatory diseases Front. Immunol. 10 2035 10.3389/fimmu.2019.02035 31543877
Karki R. Sharma B.R. Tuladhar S. Williams E.P. Zalduondo L. Samir P. Zheng M. Sundaram B. Banoth B. Malireddi R.K.S. 2021 Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes Cell 184 149 168.e17 33278357
King C. Sprent J. 2021 Dual nature of type I interferons in SARS-CoV-2-induced inflammation Trends Immunol. 42 312 322 10.1016/j.it.2021.02.003 33622601
Laing A.G. Lorenc A. Del Molino Del Barrio I. Das A. Fish M. Monin L. Munoz-Ruiz M. McKenzie D.R. Hayday T.S. Francos-Quijorna I. 2020 A dynamic COVID-19 immune signature includes associations with poor prognosis Nat. Med. 26 1623 1635 10.1038/s41591-020-1038-6 32807934
Lee J.S. Park S. Jeong H.W. Ahn J.Y. Choi S.J. Lee H. Choi B. Nam S.K. Sa M. Kwon J.S. 2020 Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 Sci. Immunol. 5 eabd1554 10.1126/sciimmunol.abd1554 32651212
Liao M. Liu Y. Yuan J. Wen Y. Xu G. Zhao J. Cheng L. Li J. Wang X. Wang F. 2020 Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 Nat. Med. 26 842 844 10.1038/s41591-020-0901-9 32398875
Lucas C. Wong P. Klein J. Castro T.B.R. Silva J. Sundaram M. Ellingson M.K. Mao T. Oh J.E. Israelow B. 2020 Longitudinal analyses reveal immunological misfiring in severe COVID-19 Nature 584 463 469 10.1038/s41586-020-2588-y 32717743
Mann E.R. Menon M. Knight S.B. Konkel J.E. Jagger C. Shaw T.N. Krishnan S. Rattray M. Ustianowski A. Bakerly N.D. 2020 Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 Sci. Immunol. 5 eabd6197 10.1126/sciimmunol.abd6197 32943497
McNab F. Mayer-Barber K. Sher A. Wack A. O'Garra A. 2015 Type I interferons in infectious disease Nat. Rev. Immunol. 15 87 103 10.1038/nri3787 25614319
Merad M. Martin J.C. 2020 Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Nat. Rev. Immunol. 20 355 362 10.1038/s41577-020-0331-4 32376901
Middleton E.A. He X.Y. Denorme F. Campbell R.A. Ng D. Salvatore S.P. Mostyka M. Baxter-Stoltzfus A. Borczuk A.C. Loda M. 2020 Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome Blood 136 1169 1179 10.1182/blood.2020007008 32597954
Netea M.G. Giamarellos-Bourboulis E.J. Dominguez-Andres J. Curtis N. van Crevel R. van de Veerdonk F.L. Bonten M. 2020 Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection Cell 181 969 977 10.1016/j.cell.2020.04.042 32437659
Nie X. Qian L. Sun R. Huang B. Dong X. Xiao Q. Zhang Q. Lu T. Yue L. Chen S. 2021 Multi-organ proteomic landscape of COVID-19 autopsies Cell 184 775 791.e14 10.1016/j.cell.2021.01.004 33503446
Park A. Iwasaki A. 2020 Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19 Cell Host Microbe 27 870 878 10.1016/j.chom.2020.05.008 32464097
Park S.H. Kang K. Giannopoulou E. Qiao Y. Kang K. Kim G. Park-Min K.H. Ivashkiv L.B. 2017 Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation Nat. Immunol. 18 1104 1116 10.1038/ni.3818 28825701
Platanitis E. Decker T. 2018 Regulatory networks involving STATs, IRFs, and NFkappaB in inflammation Front. Immunol. 9 2542 30483250
Radermecker C. Detrembleur N. Guiot J. Cavalier E. Henket M. d'Emal C. Vanwinge C. Cataldo D. Oury C. Delvenne P. 2020 Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19 J. Exp. Med. 217 e20201012 10.1084/jem.20201012 32926097
Ramlall V. Thangaraj P.M. Meydan C. Foox J. Butler D. Kim J. May B. De Freitas J.K. Glicksberg B.S. Mason C.E. 2020 Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection Nat. Med. 26 1609 1615 10.1038/s41591-020-1021-2 32747830
Horby P. Lim W.S. Emberson J.R. Mafham M. Bell J.L. Linsell L. Staplin N. Brightling C. Ustianowski A. RECOVERY Collaborative Group 2021 Dexamethasone in hospitalized patients with Covid-19 N. Engl. J. Med. 384 693 704 10.1056/NEJMoa2021436 32678530
Ren X. Wen W. Fan X. Hou W. Su B. Cai P. Li J. Liu Y. Tang F. Zhang F. 2021 COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas Cell 184 1895 1913.e19 10.1016/j.cell.2021.01.053 33657410
Rodrigues T.S. de Sa K.S.G. Ishimoto A.Y. Becerra A. Oliveira S. Almeida L. Goncalves A.V. Perucello D.B. Andrade W.A. Castro R. 2021 Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients J. Exp. Med. 218 e20201707 10.1084/jem.20201707 33231615
Schoggins J.W. Rice C.M. 2011 Interferon-stimulated genes and their antiviral effector functions Curr. Opin. Virol. 1 519 525 10.1016/j.coviro.2011.10.008 22328912
Schulte-Schrepping J. Reusch N. Paclik D. Bassler K. Schlickeiser S. Zhang B. Kramer B. Krammer T. Brumhard S. Bonaguro L. 2020 Severe COVID-19 is marked by a dysregulated myeloid cell compartment Cell 182 1419 1440.e23 10.1016/j.cell.2020.08.001 32810438
Sheahan T. Morrison T.E. Funkhouser W. Uematsu S. Akira S. Baric R.S. Heise M.T. 2008 MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV PLoS Pathog. 4 e1000240 10.1371/journal.ppat.1000240 19079579
Shen B. Yi X. Sun Y. Bi X. Du J. Zhang C. Quan S. Zhang F. Sun R. Qian L. 2020 Proteomic and metabolomic characterization of COVID-19 patient sera Cell 182 59 72.e15 10.1016/j.cell.2020.05.032 32492406
Shi L. Zhang Z. Yu A.M. Wang W. Wei Z. Akhter E. Maurer K. Costa Reis P. Song L. Petri M. 2014 The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs PLoS One 9 e93846 10.1371/journal.pone.0093846 24796678
Shin D. Mukherjee R. Grewe D. Bojkova D. Baek K. Bhattacharya A. Schulz L. Widera M. Mehdipour A.R. Tascher G. 2020 Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity Nature 587 657 662 10.1038/s41586-020-2601-5 32726803
Silvin A. Chapuis N. Dunsmore G. Goubet A.G. Dubuisson A. Derosa L. Almire C. Henon C. Kosmider O. Droin N. 2020 Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 Cell 182 1401 1418.e18 10.1016/j.cell.2020.08.002 32810439
Sokol C.L. Luster A.D. 2015 The chemokine system in innate immunity Cold Spring Harb. Perspect. Biol. 7 a016303 10.1101/cshperspect.a016303 25635046
Su Y. Chen D. Yuan D. Lausted C. Choi J. Dai C.L. Voillet V. Duvvuri V.R. Scherler K. Troisch P. 2020 Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19 Cell 183 1479 1495.e20 10.1016/j.cell.2020.10.037 33171100
Totura A.L. Whitmore A. Agnihothram S. Schafer A. Katze M.G. Heise M.T. Baric R.S. 2015 Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection Bio 6 e00638 15 10.1128/mBio.00638-15 26015500
Vabret N. Britton G.J. Gruber C. Hegde S. Kim J. Kuksin M. Levantovsky R. Malle L. Moreira A. Park M.D. 2020 Immunology of COVID-19: current state of the science Immunity 52 910 941 10.1016/j.immuni.2020.05.002 32505227
van der Poll T. van de Veerdonk F.L. Scicluna B.P. Netea M.G. 2017 The immunopathology of sepsis and potential therapeutic targets Nat. Rev. Immunol. 17 407 420 10.1038/nri.2017.36 28436424
Venkatesh D. Ernandez T. Rosetti F. Batal I. Cullere X. Luscinskas F.W. Zhang Y. Stavrakis G. Garcia-Cardena G. Horwitz B.H. 2013 Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment Immunity 38 1025 1037 10.1016/j.immuni.2013.01.012 23623383
Wang N. Zhan Y. Zhu L. Hou Z. Liu F. Song P. Qiu F. Wang X. Zou X. Wan D. 2020 Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients Cell Host Microbe 28 455 464.e2 10.1016/j.chom.2020.07.005 32707096
Wei J. Alfajaro M.M. DeWeirdt P.C. Hanna R.E. Lu-Culligan W.J. Cai W.L. Strine M.S. Zhang S.M. Graziano V.R. Schmitz C.O. 2021 Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection Cell 184 76 91.e13 10.1016/j.cell.2020.10.028 33147444
Wilk A.J. Rustagi A. Zhao N.Q. Roque J. Martinez-Colon G.J. McKechnie J.L. Ivison G.T. Ranganath T. Vergara R. Hollis T. 2020 A single-cell atlas of the peripheral immune response in patients with severe COVID-19 Nat. Med. 26 1070 1076 10.1038/s41591-020-0944-y 32514174
Yarilina A. Park-Min K.H. Antoniv T. Hu X. Ivashkiv L.B. 2008 TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes Nat. Immunol. 9 378 387 10.1038/ni1576 18345002
Zhang Q. Bastard P. Liu Z. Le Pen J. Moncada-Velez M. Chen J. Ogishi M. Sabli I.K.D. Hodeib S. Korol C. 2020 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Science 370 eabd4570 10.1126/science.abd4570 32972995
Zhou R. To K.K. Wong Y.C. Liu L. Zhou B. Li X. Huang H. Mo Y. Luk T.Y. Lau T.T. 2020a Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses Immunity 53 864 877.e5 10.1016/j.immuni.2020.07.026 32791036
Zhou Z. Ren L. Zhang L. Zhong J. Xiao Y. Jia Z. Guo L. Yang J. Wang C. Jiang S. 2020b Heightened innate immune responses in the respiratory tract of COVID-19 patients Cell Host Microbe 27 883 890.e2 10.1016/j.chom.2020.04.017 32407669
Zhu L. Yang P. Zhao Y. Zhuang Z. Wang Z. Song R. Zhang J. Liu C. Gao Q. Xu Q. 2020 Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients Immunity 53 685 696.e3 10.1016/j.immuni.2020.07.009 32783921
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.